79 related articles for article (PubMed ID: 9690405)
41. An immunological algorithm to predict risk of high-grade rejection in cardiac transplant recipients.
Itescu S; Tung TC; Burke EM; Weinberg AD; Mancini D; Michler RE; Suciu-Foca NM; Rose EA
Lancet; 1998 Jul; 352(9124):263-70. PubMed ID: 9690405
[TBL] [Abstract][Full Text] [Related]
42. [Endomyocardial biopsy in the heart transplant patient: the state of the art].
Arbustini E; Grasso M; Diegoli M; Gavazzi A; Campana C; Martinelli L; Goggi C; Pucci A; Grossi P; Ippoliti G
G Ital Cardiol; 1991 Oct; 21(10):1107-23. PubMed ID: 1804749
[TBL] [Abstract][Full Text] [Related]
43. The challenge of endomyocardial biopsy interpretation in assessing cardiac allograft rejection.
Winters GL
Curr Opin Cardiol; 1997 Mar; 12(2):146-52. PubMed ID: 9192483
[TBL] [Abstract][Full Text] [Related]
44. Endomyocardial biopsy in the evaluation of conditions leading to cardiac transplantation and in the evaluation of cardiac allograft rejection.
McAllister HA
Tex Heart Inst J; 1995; 22(1):53-66. PubMed ID: 7787471
[No Abstract] [Full Text] [Related]
45. Anything but a biopsy: noninvasive monitoring for cardiac allograft rejection.
Mehra MR; Uber PA; Uber WE; Park MH; Scott RL
Curr Opin Cardiol; 2002 Mar; 17(2):131-6. PubMed ID: 11981244
[TBL] [Abstract][Full Text] [Related]
46. [Complications in heart transplantation: diagnosis and treatment].
Bangratz S
Presse Med; 2001 Sep; 30(24 Pt 2):8-12. PubMed ID: 11577591
[TBL] [Abstract][Full Text] [Related]
47. Is biopsy-proven cellular rejection an important clinical consideration in heart transplantation?
Kirklin JK
Curr Opin Cardiol; 2005 Mar; 20(2):127-31. PubMed ID: 15711199
[TBL] [Abstract][Full Text] [Related]
48. Biopsy-negative cardiac transplant rejection: etiology, diagnosis, and therapy.
Fishbein MC; Kobashigawa J
Curr Opin Cardiol; 2004 Mar; 19(2):166-9. PubMed ID: 15075746
[TBL] [Abstract][Full Text] [Related]
49. Rejection surveillance in pediatric heart transplant recipients: Critical reflection on the role of frequent and long-term routine surveillance endomyocardial biopsies and comprehensive review of non-invasive rejection screening tools.
Power A; Baez Hernandez N; Dipchand AI
Pediatr Transplant; 2022 May; 26(3):e14214. PubMed ID: 35178843
[TBL] [Abstract][Full Text] [Related]
50. The utilization of molecular microscope in management of heart transplant recipients in the era of noninvasive monitoring.
Mehlman Y; Valledor AF; Moeller C; Rubinstein G; Lotan D; Rahman S; Oh KT; Bae D; DeFilippis EM; Lin EF; Lee SH; Raikhelkar JK; Fried J; Theodoropoulos K; Colombo PC; Yuzefpolskaya M; Latif F; Clerkin KJ; Sayer GT; Uriel N
Clin Transplant; 2023 Dec; 37(12):e15131. PubMed ID: 37897211
[TBL] [Abstract][Full Text] [Related]
51. The challenge of rejection and cardiac allograft vasculopathy.
Cotts WG; Johnson MR
Heart Fail Rev; 2001 Sep; 6(3):227-40. PubMed ID: 11391041
[TBL] [Abstract][Full Text] [Related]
52. Noninvasive detection of cardiac transplant rejection using electronic monitoring.
Eisen HJ
Curr Opin Cardiol; 1999 Mar; 14(2):151-4. PubMed ID: 10191974
[TBL] [Abstract][Full Text] [Related]
53. Angiographic implications of cardiac transplantation.
Alderman EL; Wexler L
Am J Cardiol; 1989 Sep; 64(9):16E-21E. PubMed ID: 2672763
[TBL] [Abstract][Full Text] [Related]
54. Non-invasive approaches for the diagnosis of acute cardiac allograft rejection.
Miller CA; Fildes JE; Ray SG; Doran H; Yonan N; Williams SG; Schmitt M
Heart; 2013 Apr; 99(7):445-53. PubMed ID: 23257172
[TBL] [Abstract][Full Text] [Related]
55. Predicting outcome after cardiac transplantations: lessons from the Cardiac Transplant Research Database.
Bourge RC; Kirklin JK; Naftel DC; McGiffin DC
Curr Opin Cardiol; 1997 Mar; 12(2):136-45. PubMed ID: 9192482
[TBL] [Abstract][Full Text] [Related]
56. Microvascular coronary arterial vasculopathy--predictive value of endomyocardial biopsy.
Lozano MD
Z Kardiol; 2000; 89 Suppl 9():IX/54-7. PubMed ID: 11151794
[TBL] [Abstract][Full Text] [Related]
57. Chemokines and transplant vasculopathy.
Belperio JA; Ardehali A
Circ Res; 2008 Aug; 103(5):454-66. PubMed ID: 18757833
[TBL] [Abstract][Full Text] [Related]
58. The use and misuse of immunologic monitoring after transplantation: approaches that have proved useful.
Cook DJ; Bishay ES; Yamani M
Curr Opin Cardiol; 2000 Mar; 15(2):104-7. PubMed ID: 10963147
[TBL] [Abstract][Full Text] [Related]
59. Molecular Diagnostic Testing in Cardiac Transplantation.
Khush K; Zarafshar S
Curr Cardiol Rep; 2017 Oct; 19(11):118. PubMed ID: 29030720
[TBL] [Abstract][Full Text] [Related]
60. Antibody-medicated rejection after heart transplantation: diagnosis and clinical implications.
Nguyen VP; Kobashigawa JA
Curr Opin Organ Transplant; 2020 Jun; 25(3):248-254. PubMed ID: 32304428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
